206 related articles for article (PubMed ID: 36980274)
1. Differences in Cerebral Glucose Metabolism in ALS Patients with and without
De Vocht J; Van Weehaeghe D; Ombelet F; Masrori P; Lamaire N; Devrome M; Van Esch H; Moisse M; Koole M; Dupont P; Van Laere K; Van Damme P
Cells; 2023 Mar; 12(6):. PubMed ID: 36980274
[TBL] [Abstract][Full Text] [Related]
2. Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes.
Canosa A; Calvo A; Moglia C; Vasta R; Palumbo F; Solero L; Di Pede F; Cabras S; Arena V; Zocco G; Casale F; Brunetti M; Sbaiz L; Gallone S; Grassano M; Manera U; Pagani M; Chiò A
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2242-2250. PubMed ID: 35076740
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers.
Tondo G; Mazzini L; Caminiti SP; Sarnelli MF; Corrado L; Matheoud R; D'Alfonso S; Cantello R; Sacchetti GM; Perani D; Comi C; De Marchi F
Neuroimage Clin; 2022; 36():103222. PubMed ID: 36223668
[TBL] [Abstract][Full Text] [Related]
4. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
[TBL] [Abstract][Full Text] [Related]
5. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients.
Cistaro A; Pagani M; Montuschi A; Calvo A; Moglia C; Canosa A; Restagno G; Brunetti M; Traynor BJ; Nobili F; Carrara G; Fania P; Lopiano L; Valentini MC; Chiò A
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):844-52. PubMed ID: 24445987
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain.
Gregory JM; Livesey MR; McDade K; Selvaraj BT; Barton SK; Chandran S; Smith C
J Pathol; 2020 Jan; 250(1):67-78. PubMed ID: 31579943
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.
Castelnovo V; Caminiti SP; Riva N; Magnani G; Silani V; Perani D
Neurol Sci; 2019 Mar; 40(3):515-521. PubMed ID: 30554355
[TBL] [Abstract][Full Text] [Related]
8. Frequency of C9orf72 hexanucleotide repeat expansion and SOD1 mutations in Portuguese patients with amyotrophic lateral sclerosis.
Gromicho M; Pinto S; Gisca E; Pronto-Laborinho AC; Andersen PM; de Carvalho M
Neurobiol Aging; 2018 Oct; 70():325.e7-325.e15. PubMed ID: 29861044
[TBL] [Abstract][Full Text] [Related]
9. Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants.
Brown CA; Lally C; Kupelian V; Flanders WD
Neuroepidemiology; 2021; 55(5):342-353. PubMed ID: 34247168
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal imaging in
Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
[TBL] [Abstract][Full Text] [Related]
11. Frequency of
Yilmaz R; Grehl T; Eckrich L; Marschalkowski I; Weishaupt K; Valkadinov I; Simic M; Brenner D; Andersen PM; Wolf J; Weishaupt JH
Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; 24(5-6):414-419. PubMed ID: 36650645
[No Abstract] [Full Text] [Related]
12. Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion.
De Vocht J; Blommaert J; Devrome M; Radwan A; Van Weehaeghe D; De Schaepdryver M; Ceccarini J; Rezaei A; Schramm G; van Aalst J; Chiò A; Pagani M; Stam D; Van Esch H; Lamaire N; Verhaegen M; Mertens N; Poesen K; van den Berg LH; van Es MA; Vandenberghe R; Vandenbulcke M; Van den Stock J; Koole M; Dupont P; Van Laere K; Van Damme P
JAMA Neurol; 2020 Aug; 77(8):1008-1017. PubMed ID: 32421156
[TBL] [Abstract][Full Text] [Related]
13. Motor neurons from ALS patients with mutations in C9ORF72 and SOD1 exhibit distinct transcriptional landscapes.
Wong CO; Venkatachalam K
Hum Mol Genet; 2019 Aug; 28(16):2799-2810. PubMed ID: 31107959
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the clinical and cognitive features of genetically positive ALS patients from the largest tertiary center in Serbia.
Marjanović IV; Selak-Djokić B; Perić S; Janković M; Arsenijević V; Basta I; Lavrnić D; Stefanova E; Stević Z
J Neurol; 2017 Jun; 264(6):1091-1098. PubMed ID: 28444446
[TBL] [Abstract][Full Text] [Related]
15. Reduced mitochondrial D-loop methylation levels in sporadic amyotrophic lateral sclerosis.
Stoccoro A; Smith AR; Mosca L; Marocchi A; Gerardi F; Lunetta C; Cereda C; Gagliardi S; Lunnon K; Migliore L; Coppedè F
Clin Epigenetics; 2020 Sep; 12(1):137. PubMed ID: 32917270
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of the SOD1 and C9ORF72 genes in Hungarian patients with amyotrophic lateral sclerosis.
Tripolszki K; Csányi B; Nagy D; Ratti A; Tiloca C; Silani V; Kereszty É; Török N; Vécsei L; Engelhardt JI; Klivényi P; Nagy N; Széll M
Neurobiol Aging; 2017 May; 53():195.e1-195.e5. PubMed ID: 28222900
[TBL] [Abstract][Full Text] [Related]
17. In vivo histopathological staging in C9orf72-associated ALS: A tract of interest DTI study.
Müller HP; Del Tredici K; Lulé D; Müller K; Weishaupt JH; Ludolph AC; Kassubek J
Neuroimage Clin; 2020; 27():102298. PubMed ID: 32505118
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of SOD1, C9orf72, TARDBP and FUS genes in ethnically-diverse Malaysian patients with amyotrophic lateral sclerosis (ALS).
Edgar S; Ellis M; Abdul-Aziz NA; Goh KJ; Shahrizaila N; Kennerson ML; Ahmad-Annuar A
Neurobiol Aging; 2021 Dec; 108():200-206. PubMed ID: 34404558
[TBL] [Abstract][Full Text] [Related]
19. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
[TBL] [Abstract][Full Text] [Related]
20. Deficits in verbal fluency in presymptomatic
Lulé DE; Müller HP; Finsel J; Weydt P; Knehr A; Winroth I; Andersen P; Weishaupt J; Uttner I; Kassubek J; Ludolph AC
J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1195-1200. PubMed ID: 32855285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
